Edgewise Therapeutics, Inc.
NASDAQEdgewise Therapeutics heads into mid-June with a notable divergence: the Street is turning more bullish at precisely the moment short sellers are adding exposure and options traders are flashing their most defensive reading in months. The analyst catalyst is the headline this week. RBC Capital raised its price target to $59 from $48 — a 23% lift — while maintaining its Outperform…
Snapshot as of 18 Jun 2026
Edgewise Therapeutics heads into mid-June with a notable divergence: the Street is turning more bullish at precisely the moment short sellers are adding exposure and options traders are flashing their most defensive…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EWTX — free to start on ORTEX.
Sign up for free →Open EWTX on ORTEX